This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Diwan, B. A. Articles by Ward, J. M. Search for Related Content PubMed PubMed Citation Articles by Diwan, B. A. Articles by Ward, J. M.

P-450 Enzyme Induction by 5-Ethyl-5-phenylhydantoin and 5,5-Diethylhydantoin, Analogues of Barbiturate Tumor Promoters Phenobarbital and Barbital, and Promotion of Liver and Thyroid Carcinogenesis Initiated by N-Nitrosodiethylamine in Rats¹

Program Resources, Inc., Frederick Cancer Research Facility, Frederick, Maryland 21701 [B. A. D.], and Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick, Maryland 21701 [J. M. R., R. W. N., R. A. L., J. M. W.]

Male F344/NCr rats, 6 wk old, were fed 500 ppm of phenobarbital (PB) or equimolar doses of either 5-ethyl-5-phenylhydantoin (EPH) or 5,5-diethylhydantoin (EEH) in diet for 2 wk and hepatic cytochrome P-450-mediated alkoxyresorufin O-dealkylase and aminopyrine N-demethylase activities were determined. Both PB and EPH greatly increased P-450-mediated enzyme activities in rat liver while EEH was ineffective. To evaluate the hydantoins as tumor promoters, 5-wk-old male F344 rats were given a single i.p. injection of 75 mg N-nitrosodiethylamine/kg body weight. Beginning 2 wk later, they were placed either on normal diet or diet containing 500 ppm of PB or equimolar doses of EPH or EEH for the remaining experimental period. Control groups received an i.p. injection of saline followed by each of the test diets. Animals were sacrificed at either 52 or 78 wk. PB and EPH significantly enhanced the development of hepatocellular foci and hepatocellular adenomas at 52 wk and hepatocellular carcinomas at 78 wk in N-nitrosodiethylamine-initiated rats. Neither the incidence of hepatocellular neoplasms nor the number and size of hepatocellular foci was significantly increased by EEH. At 78 wk, both PB and EPH enhanced the development of thyroid follicular cell neoplasms in N-nitrosodiethylamine-initiated rats while no such enhancement was observed with EEH. Thus, EPH, a long-acting sedative/anticonvulsant, like the structurally similar PB, promoted hepatocellular and thyroid follicular cell carcinogenesis and induced the PB-inducible form(s) of cytochrome P-450 (P-450_b) in rats. In contrast, EEH unlike barbital failed to promote hepatocellular and thyroid follicular cell carcinogenesis and also failed to induce PB-inducible form(s) of cytochrome P-450 in rats.

¹ Supported in part by the National Cancer Institute under Contract NO1-CO-23910 with Program Resources, Inc.

² To whom requests for reprints should be addressed.

³ Present address: Johns Hopkins Applied Physics Laboratory, Laurel, MD 20707.

Received 10/21/87. Revised 1/29/88. Accepted 2/ 4/88.

This article has been cited by other articles:

				G. Singh, P. H. Driever, and J. W. Sander Cancer risk in people with epilepsy: the role of antiepileptic drugs Brain, January 1, 2005; 128(1): 7 - 17. [Abstract] [Full Text] [PDF]

				D. Ramljak, R. J. Calvert, P. W. Wiesenfeld, B. A. Diwan, B. Catipovic, W. F.O. Marasas, T. C. Victor, L. M. Anderson, and W. C.A. Gelderblom A potential mechanism for fumonisin B1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3{beta} activity Carcinogenesis, August 1, 2000; 21(8): 1537 - 1546. [Abstract] [Full Text] [PDF]

				T. Shoda, K. Mitsumori, H. Onodera, K. Toyoda, C. Uneyama, K. Takada, and M. Hirose Live Tumor-Promoting Effect of {beta}-Naphthoflavone, a Strong CYP 1A1/2 Inducer, and the Relationship between CYP 1A1/2 Induction and Cx32 Decrease in Its Hepatocarcinogenesis in the Rat Toxicol Pathol, July 1, 2000; 28(4): 540 - 547. [Abstract] [PDF]

				A. Hood and C. D. Klaassen Differential Effects of Microsomal Enzyme Inducers on in Vitro Thyroxine (T4) and Triiodothyronine (T3) Glucuronidation Toxicol. Sci., May 1, 2000; 55(1): 78 - 84. [Abstract] [Full Text] [PDF]

				D. L. Gustafson, M. E. Long, R. S. Thomas, S. A. Benjamin, and R. S. H. Yang Comparative Hepatocarcinogenicity of Hexachlorobenzene, Pentachlorobenzene, 1,2,4,5-Tetrachlorobenzene, and 1,4-Dichlorobenzene: Application of a Medium-Term Liver Focus Bioassay and Molecular and Cellular Indices Toxicol. Sci., February 1, 2000; 53(2): 245 - 252. [Abstract] [Full Text] [PDF]

				T. Shoda, H. Onodera, M. Takeda, C. Uneyama, T. Imazawa, K. Takegawa, K. Yasuhara, T. Watanabe, M. Hirose, and K. Mitsumori Liver Tumor Promoting Effects of Fenbendazole in Rats Toxicol Pathol, September 1, 1999; 27(5): 553 - 562. [Abstract] [PDF]

				R. W. Nims, R. A. Prough, C. R. Jones, D. L. Stockus, K. H. Dragnev, P. E. Thomas, and R. A. Lubet In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam Drug Metab. Dispos., June 1, 1997; 25(6): 750 - 756. [Abstract] [Full Text]

				L. A Dethloff, M. J Graziano, E. Goldenthal, A. Gough, and F. A de la Iglesia Perspective on the carcinogenic potential of phenytoin based on rodent tumor bioassays and human epidemiological data Human and Experimental Toxicology, April 1, 1996; 15(4): 335 - 348. [Abstract] [PDF]

				S. Johnson, D. McKillop, J. Miller, and I.K. Smith The Effects on Rat Thyroid Function of an Hepatic Microsomal Enzyme Inducer Human and Experimental Toxicology, January 1, 1993; 12(2): 153 - 158. [Abstract] [PDF]

				R. A. Lubet, R. W. Nims, J. M. Ward, J. M. Rice, and B. A. Diwan Induction of Cytochrome P450b and Its Relationship to Liver Tumor Promotion International Journal of Toxicology, March 1, 1989; 8(2): 259 - 268. [Abstract] [PDF]